nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—Lisinopril—dilated cardiomyopathy	0.375	1	CrCtD
Fosinopril—ACE—dilated cardiomyopathy	0.164	1	CbGaD
Fosinopril—ACE—Lisinopril—dilated cardiomyopathy	0.135	0.714	CbGbCtD
Fosinopril—SLC15A1—Lisinopril—dilated cardiomyopathy	0.0543	0.286	CbGbCtD
Fosinopril—Spirapril—Lisinopril—dilated cardiomyopathy	0.0452	0.208	CrCrCtD
Fosinopril—Cilazapril—Lisinopril—dilated cardiomyopathy	0.0452	0.208	CrCrCtD
Fosinopril—Enalapril—Lisinopril—dilated cardiomyopathy	0.0424	0.195	CrCrCtD
Fosinopril—Trandolapril—Lisinopril—dilated cardiomyopathy	0.0424	0.195	CrCrCtD
Fosinopril—Ramipril—Lisinopril—dilated cardiomyopathy	0.0424	0.195	CrCrCtD
Fosinopril—ACE—pulmonary artery—dilated cardiomyopathy	0.00261	0.364	CbGeAlD
Fosinopril—ACE—sympathetic nervous system—dilated cardiomyopathy	0.00254	0.354	CbGeAlD
Fosinopril—ACE—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.0018	0.284	CbGpPWpGaD
Fosinopril—ACE—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.0014	0.221	CbGpPWpGaD
Fosinopril—Pulmonary eosinophilia—Lisinopril—dilated cardiomyopathy	0.000911	0.0232	CcSEcCtD
Fosinopril—Pemphigus—Lisinopril—dilated cardiomyopathy	0.000868	0.0221	CcSEcCtD
Fosinopril—ACE—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.000754	0.119	CbGpPWpGaD
Fosinopril—Antinuclear antibody positive—Lisinopril—dilated cardiomyopathy	0.000733	0.0187	CcSEcCtD
Fosinopril—Polydipsia—Furosemide—dilated cardiomyopathy	0.000715	0.0182	CcSEcCtD
Fosinopril—Hypovolaemia—Furosemide—dilated cardiomyopathy	0.000715	0.0182	CcSEcCtD
Fosinopril—ACE—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.00058	0.0917	CbGpPWpGaD
Fosinopril—ACE—cardiac ventricle—dilated cardiomyopathy	0.000544	0.0757	CbGeAlD
Fosinopril—ACE—myocardium—dilated cardiomyopathy	0.000511	0.0712	CbGeAlD
Fosinopril—Anuria—Lisinopril—dilated cardiomyopathy	0.000476	0.0121	CcSEcCtD
Fosinopril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—dilated cardiomyopathy	0.000428	0.0677	CbGpPWpGaD
Fosinopril—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000418	0.0106	CcSEcCtD
Fosinopril—ACE—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.000408	0.0645	CbGpPWpGaD
Fosinopril—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0004	0.0102	CcSEcCtD
Fosinopril—ACE—heart—dilated cardiomyopathy	0.000357	0.0497	CbGeAlD
Fosinopril—Transient ischaemic attack—Lisinopril—dilated cardiomyopathy	0.00033	0.0084	CcSEcCtD
Fosinopril—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.000328	0.00836	CcSEcCtD
Fosinopril—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00032	0.00816	CcSEcCtD
Fosinopril—Renal pain—Lisinopril—dilated cardiomyopathy	0.000316	0.00806	CcSEcCtD
Fosinopril—SLC15A2—heart—dilated cardiomyopathy	0.000311	0.0433	CbGeAlD
Fosinopril—Blister—Furosemide—dilated cardiomyopathy	0.000308	0.00783	CcSEcCtD
Fosinopril—ACE—cardiac atrium—dilated cardiomyopathy	0.000305	0.0425	CbGeAlD
Fosinopril—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.000297	0.00756	CcSEcCtD
Fosinopril—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00029	0.00737	CcSEcCtD
Fosinopril—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.000276	0.00702	CcSEcCtD
Fosinopril—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.00027	0.00689	CcSEcCtD
Fosinopril—Spirapril—ACE—dilated cardiomyopathy	0.000267	0.194	CrCbGaD
Fosinopril—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000266	0.00678	CcSEcCtD
Fosinopril—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.000266	0.00678	CcSEcCtD
Fosinopril—Gastritis—Spironolactone—dilated cardiomyopathy	0.000262	0.00667	CcSEcCtD
Fosinopril—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000253	0.00645	CcSEcCtD
Fosinopril—Heartburn—Lisinopril—dilated cardiomyopathy	0.000242	0.00616	CcSEcCtD
Fosinopril—Drug interaction—Furosemide—dilated cardiomyopathy	0.000239	0.00609	CcSEcCtD
Fosinopril—Cilazapril—ACE—dilated cardiomyopathy	0.000238	0.173	CrCbGaD
Fosinopril—Lisinopril—ACE—dilated cardiomyopathy	0.000238	0.173	CrCbGaD
Fosinopril—Gout—Furosemide—dilated cardiomyopathy	0.000237	0.00605	CcSEcCtD
Fosinopril—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.000235	0.006	CcSEcCtD
Fosinopril—Laryngitis—Lisinopril—dilated cardiomyopathy	0.000231	0.00588	CcSEcCtD
Fosinopril—Trandolapril—ACE—dilated cardiomyopathy	0.000231	0.167	CrCbGaD
Fosinopril—Ramipril—ACE—dilated cardiomyopathy	0.000231	0.167	CrCbGaD
Fosinopril—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000228	0.00581	CcSEcCtD
Fosinopril—Vasculitis—Furosemide—dilated cardiomyopathy	0.000227	0.00579	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000226	0.00576	CcSEcCtD
Fosinopril—Renal failure—Spironolactone—dilated cardiomyopathy	0.000224	0.00571	CcSEcCtD
Fosinopril—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000213	0.00542	CcSEcCtD
Fosinopril—Memory impairment—Lisinopril—dilated cardiomyopathy	0.000212	0.0054	CcSEcCtD
Fosinopril—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.000208	0.0053	CcSEcCtD
Fosinopril—Urine output increased—Furosemide—dilated cardiomyopathy	0.0002	0.00511	CcSEcCtD
Fosinopril—Lightheadedness—Furosemide—dilated cardiomyopathy	0.000198	0.00505	CcSEcCtD
Fosinopril—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000194	0.00493	CcSEcCtD
Fosinopril—Proteinuria—Lisinopril—dilated cardiomyopathy	0.000189	0.00482	CcSEcCtD
Fosinopril—Protein urine present—Lisinopril—dilated cardiomyopathy	0.000187	0.00476	CcSEcCtD
Fosinopril—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000185	0.00471	CcSEcCtD
Fosinopril—Viral infection—Lisinopril—dilated cardiomyopathy	0.000184	0.00469	CcSEcCtD
Fosinopril—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000183	0.00467	CcSEcCtD
Fosinopril—Polyuria—Furosemide—dilated cardiomyopathy	0.000183	0.00467	CcSEcCtD
Fosinopril—Swelling—Furosemide—dilated cardiomyopathy	0.000182	0.00465	CcSEcCtD
Fosinopril—Oliguria—Lisinopril—dilated cardiomyopathy	0.000181	0.0046	CcSEcCtD
Fosinopril—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00018	0.00458	CcSEcCtD
Fosinopril—Drug interaction—Lisinopril—dilated cardiomyopathy	0.000179	0.00457	CcSEcCtD
Fosinopril—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000178	0.00454	CcSEcCtD
Fosinopril—Gout—Lisinopril—dilated cardiomyopathy	0.000178	0.00454	CcSEcCtD
Fosinopril—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000177	0.00451	CcSEcCtD
Fosinopril—Enalapril—ACE—dilated cardiomyopathy	0.000175	0.127	CrCbGaD
Fosinopril—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.000175	0.00445	CcSEcCtD
Fosinopril—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000171	0.00436	CcSEcCtD
Fosinopril—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000171	0.00434	CcSEcCtD
Fosinopril—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00017	0.00434	CcSEcCtD
Fosinopril—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000168	0.00429	CcSEcCtD
Fosinopril—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.000168	0.00429	CcSEcCtD
Fosinopril—Purpura—Furosemide—dilated cardiomyopathy	0.000167	0.00425	CcSEcCtD
Fosinopril—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000166	0.00423	CcSEcCtD
Fosinopril—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000165	0.00421	CcSEcCtD
Fosinopril—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000163	0.00416	CcSEcCtD
Fosinopril—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.000162	0.00412	CcSEcCtD
Fosinopril—Malaise—Spironolactone—dilated cardiomyopathy	0.000161	0.00409	CcSEcCtD
Fosinopril—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000159	0.00406	CcSEcCtD
Fosinopril—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000156	0.00398	CcSEcCtD
Fosinopril—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000151	0.00384	CcSEcCtD
Fosinopril—Discomfort—Spironolactone—dilated cardiomyopathy	0.00015	0.00382	CcSEcCtD
Fosinopril—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000149	0.00379	CcSEcCtD
Fosinopril—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000148	0.00377	CcSEcCtD
Fosinopril—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000147	0.00374	CcSEcCtD
Fosinopril—Confusional state—Spironolactone—dilated cardiomyopathy	0.000147	0.00373	CcSEcCtD
Fosinopril—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000145	0.0037	CcSEcCtD
Fosinopril—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000145	0.00369	CcSEcCtD
Fosinopril—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000145	0.00369	CcSEcCtD
Fosinopril—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000142	0.00363	CcSEcCtD
Fosinopril—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000142	0.00362	CcSEcCtD
Fosinopril—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00014	0.00357	CcSEcCtD
Fosinopril—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00014	0.00355	CcSEcCtD
Fosinopril—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000139	0.00354	CcSEcCtD
Fosinopril—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000138	0.00351	CcSEcCtD
Fosinopril—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000138	0.0035	CcSEcCtD
Fosinopril—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000136	0.00347	CcSEcCtD
Fosinopril—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000136	0.00347	CcSEcCtD
Fosinopril—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000134	0.00342	CcSEcCtD
Fosinopril—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000134	0.00341	CcSEcCtD
Fosinopril—Injury—Lisinopril—dilated cardiomyopathy	0.000131	0.00335	CcSEcCtD
Fosinopril—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000131	0.00333	CcSEcCtD
Fosinopril—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00013	0.00332	CcSEcCtD
Fosinopril—Somnolence—Spironolactone—dilated cardiomyopathy	0.000129	0.00329	CcSEcCtD
Fosinopril—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000129	0.00327	CcSEcCtD
Fosinopril—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000127	0.00323	CcSEcCtD
Fosinopril—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000125	0.00318	CcSEcCtD
Fosinopril—Arthritis—Lisinopril—dilated cardiomyopathy	0.000124	0.00316	CcSEcCtD
Fosinopril—Drowsiness—Furosemide—dilated cardiomyopathy	0.000124	0.00316	CcSEcCtD
Fosinopril—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000123	0.00314	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000123	0.00313	CcSEcCtD
Fosinopril—Renal failure—Furosemide—dilated cardiomyopathy	0.000122	0.0031	CcSEcCtD
Fosinopril—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.000121	0.00309	CcSEcCtD
Fosinopril—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00012	0.00305	CcSEcCtD
Fosinopril—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00012	0.00305	CcSEcCtD
Fosinopril—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000116	0.00295	CcSEcCtD
Fosinopril—Urticaria—Spironolactone—dilated cardiomyopathy	0.000116	0.00294	CcSEcCtD
Fosinopril—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000115	0.00293	CcSEcCtD
Fosinopril—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000115	0.00292	CcSEcCtD
Fosinopril—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000113	0.00288	CcSEcCtD
Fosinopril—ACE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	0.000113	0.0178	CbGpPWpGaD
Fosinopril—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00011	0.00281	CcSEcCtD
Fosinopril—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000109	0.00278	CcSEcCtD
Fosinopril—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000109	0.00277	CcSEcCtD
Fosinopril—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000109	0.00277	CcSEcCtD
Fosinopril—Visual impairment—Furosemide—dilated cardiomyopathy	0.000107	0.00273	CcSEcCtD
Fosinopril—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000107	0.00273	CcSEcCtD
Fosinopril—Gastritis—Lisinopril—dilated cardiomyopathy	0.000107	0.00272	CcSEcCtD
Fosinopril—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000105	0.00268	CcSEcCtD
Fosinopril—Influenza—Lisinopril—dilated cardiomyopathy	0.000104	0.00266	CcSEcCtD
Fosinopril—Asthma—Lisinopril—dilated cardiomyopathy	0.000104	0.00266	CcSEcCtD
Fosinopril—Tinnitus—Furosemide—dilated cardiomyopathy	0.000104	0.00264	CcSEcCtD
Fosinopril—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000103	0.00263	CcSEcCtD
Fosinopril—Pruritus—Spironolactone—dilated cardiomyopathy	0.000103	0.00262	CcSEcCtD
Fosinopril—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000103	0.00261	CcSEcCtD
Fosinopril—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000102	0.00261	CcSEcCtD
Fosinopril—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000102	0.00259	CcSEcCtD
Fosinopril—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000102	0.00259	CcSEcCtD
Fosinopril—Diarrhoea—Spironolactone—dilated cardiomyopathy	9.95e-05	0.00253	CcSEcCtD
Fosinopril—Arrhythmia—Furosemide—dilated cardiomyopathy	9.95e-05	0.00253	CcSEcCtD
Fosinopril—Pancytopenia—Lisinopril—dilated cardiomyopathy	9.91e-05	0.00252	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	9.87e-05	0.0156	CbGpPWpGaD
Fosinopril—ACE—Metabolism of proteins—TAZ—dilated cardiomyopathy	9.87e-05	0.0156	CbGpPWpGaD
Fosinopril—SLC15A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.83e-05	0.0155	CbGpPWpGaD
Fosinopril—Neutropenia—Lisinopril—dilated cardiomyopathy	9.76e-05	0.00249	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	9.7e-05	0.00247	CcSEcCtD
Fosinopril—Dizziness—Spironolactone—dilated cardiomyopathy	9.62e-05	0.00245	CcSEcCtD
Fosinopril—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	9.61e-05	0.00245	CcSEcCtD
Fosinopril—Flatulence—Furosemide—dilated cardiomyopathy	9.55e-05	0.00243	CcSEcCtD
Fosinopril—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	9.53e-05	0.00243	CcSEcCtD
Fosinopril—Weight increased—Lisinopril—dilated cardiomyopathy	9.5e-05	0.00242	CcSEcCtD
Fosinopril—Dysgeusia—Furosemide—dilated cardiomyopathy	9.49e-05	0.00242	CcSEcCtD
Fosinopril—Weight decreased—Lisinopril—dilated cardiomyopathy	9.44e-05	0.0024	CcSEcCtD
Fosinopril—Pneumonia—Lisinopril—dilated cardiomyopathy	9.36e-05	0.00238	CcSEcCtD
Fosinopril—Muscle spasms—Furosemide—dilated cardiomyopathy	9.32e-05	0.00237	CcSEcCtD
Fosinopril—Vomiting—Spironolactone—dilated cardiomyopathy	9.25e-05	0.00235	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	9.23e-05	0.00235	CcSEcCtD
Fosinopril—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	9.17e-05	0.00234	CcSEcCtD
Fosinopril—Rash—Spironolactone—dilated cardiomyopathy	9.17e-05	0.00233	CcSEcCtD
Fosinopril—Dermatitis—Spironolactone—dilated cardiomyopathy	9.16e-05	0.00233	CcSEcCtD
Fosinopril—Renal failure—Lisinopril—dilated cardiomyopathy	9.15e-05	0.00233	CcSEcCtD
Fosinopril—Vision blurred—Furosemide—dilated cardiomyopathy	9.14e-05	0.00233	CcSEcCtD
Fosinopril—SLC15A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	9.13e-05	0.0144	CbGpPWpGaD
Fosinopril—Myocardial infarction—Lisinopril—dilated cardiomyopathy	9.12e-05	0.00232	CcSEcCtD
Fosinopril—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	9.12e-05	0.00232	CcSEcCtD
Fosinopril—Headache—Spironolactone—dilated cardiomyopathy	9.11e-05	0.00232	CcSEcCtD
Fosinopril—Jaundice—Lisinopril—dilated cardiomyopathy	9.07e-05	0.00231	CcSEcCtD
Fosinopril—Anaemia—Furosemide—dilated cardiomyopathy	8.96e-05	0.00228	CcSEcCtD
Fosinopril—Agitation—Furosemide—dilated cardiomyopathy	8.91e-05	0.00227	CcSEcCtD
Fosinopril—Epistaxis—Lisinopril—dilated cardiomyopathy	8.78e-05	0.00224	CcSEcCtD
Fosinopril—Sinusitis—Lisinopril—dilated cardiomyopathy	8.73e-05	0.00222	CcSEcCtD
Fosinopril—Vertigo—Furosemide—dilated cardiomyopathy	8.71e-05	0.00222	CcSEcCtD
Fosinopril—Agranulocytosis—Lisinopril—dilated cardiomyopathy	8.68e-05	0.00221	CcSEcCtD
Fosinopril—Leukopenia—Furosemide—dilated cardiomyopathy	8.68e-05	0.00221	CcSEcCtD
Fosinopril—Nausea—Spironolactone—dilated cardiomyopathy	8.64e-05	0.0022	CcSEcCtD
Fosinopril—Bradycardia—Lisinopril—dilated cardiomyopathy	8.51e-05	0.00217	CcSEcCtD
Fosinopril—Rhinitis—Lisinopril—dilated cardiomyopathy	8.38e-05	0.00213	CcSEcCtD
Fosinopril—Hepatitis—Lisinopril—dilated cardiomyopathy	8.35e-05	0.00213	CcSEcCtD
Fosinopril—Hallucination—Lisinopril—dilated cardiomyopathy	8.31e-05	0.00212	CcSEcCtD
Fosinopril—Pharyngitis—Lisinopril—dilated cardiomyopathy	8.29e-05	0.00211	CcSEcCtD
Fosinopril—Oedema peripheral—Lisinopril—dilated cardiomyopathy	8.23e-05	0.0021	CcSEcCtD
Fosinopril—Dry mouth—Furosemide—dilated cardiomyopathy	8.07e-05	0.00206	CcSEcCtD
Fosinopril—Confusional state—Furosemide—dilated cardiomyopathy	7.98e-05	0.00203	CcSEcCtD
Fosinopril—Anaphylactic shock—Furosemide—dilated cardiomyopathy	7.91e-05	0.00201	CcSEcCtD
Fosinopril—Erythema multiforme—Lisinopril—dilated cardiomyopathy	7.9e-05	0.00201	CcSEcCtD
Fosinopril—Tinnitus—Lisinopril—dilated cardiomyopathy	7.79e-05	0.00198	CcSEcCtD
Fosinopril—Shock—Furosemide—dilated cardiomyopathy	7.78e-05	0.00198	CcSEcCtD
Fosinopril—Flushing—Lisinopril—dilated cardiomyopathy	7.75e-05	0.00197	CcSEcCtD
Fosinopril—Thrombocytopenia—Furosemide—dilated cardiomyopathy	7.75e-05	0.00197	CcSEcCtD
Fosinopril—Hyperhidrosis—Furosemide—dilated cardiomyopathy	7.65e-05	0.00195	CcSEcCtD
Fosinopril—Anorexia—Furosemide—dilated cardiomyopathy	7.54e-05	0.00192	CcSEcCtD
Fosinopril—Chills—Lisinopril—dilated cardiomyopathy	7.5e-05	0.00191	CcSEcCtD
Fosinopril—Arrhythmia—Lisinopril—dilated cardiomyopathy	7.46e-05	0.0019	CcSEcCtD
Fosinopril—Hypotension—Furosemide—dilated cardiomyopathy	7.39e-05	0.00188	CcSEcCtD
Fosinopril—Flatulence—Lisinopril—dilated cardiomyopathy	7.17e-05	0.00182	CcSEcCtD
Fosinopril—Tension—Lisinopril—dilated cardiomyopathy	7.14e-05	0.00182	CcSEcCtD
Fosinopril—Dysgeusia—Lisinopril—dilated cardiomyopathy	7.12e-05	0.00181	CcSEcCtD
Fosinopril—Paraesthesia—Furosemide—dilated cardiomyopathy	7.1e-05	0.00181	CcSEcCtD
Fosinopril—Nervousness—Lisinopril—dilated cardiomyopathy	7.06e-05	0.0018	CcSEcCtD
Fosinopril—Somnolence—Furosemide—dilated cardiomyopathy	7.03e-05	0.00179	CcSEcCtD
Fosinopril—Muscle spasms—Lisinopril—dilated cardiomyopathy	6.99e-05	0.00178	CcSEcCtD
Fosinopril—Decreased appetite—Furosemide—dilated cardiomyopathy	6.88e-05	0.00175	CcSEcCtD
Fosinopril—Vision blurred—Lisinopril—dilated cardiomyopathy	6.85e-05	0.00175	CcSEcCtD
Fosinopril—Fatigue—Furosemide—dilated cardiomyopathy	6.82e-05	0.00174	CcSEcCtD
Fosinopril—Tremor—Lisinopril—dilated cardiomyopathy	6.81e-05	0.00174	CcSEcCtD
Fosinopril—Constipation—Furosemide—dilated cardiomyopathy	6.76e-05	0.00172	CcSEcCtD
Fosinopril—Pain—Furosemide—dilated cardiomyopathy	6.76e-05	0.00172	CcSEcCtD
Fosinopril—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	6.75e-05	0.00172	CcSEcCtD
Fosinopril—Anaemia—Lisinopril—dilated cardiomyopathy	6.72e-05	0.00171	CcSEcCtD
Fosinopril—Angioedema—Lisinopril—dilated cardiomyopathy	6.65e-05	0.00169	CcSEcCtD
Fosinopril—Malaise—Lisinopril—dilated cardiomyopathy	6.56e-05	0.00167	CcSEcCtD
Fosinopril—Vertigo—Lisinopril—dilated cardiomyopathy	6.53e-05	0.00166	CcSEcCtD
Fosinopril—Syncope—Lisinopril—dilated cardiomyopathy	6.52e-05	0.00166	CcSEcCtD
Fosinopril—Feeling abnormal—Furosemide—dilated cardiomyopathy	6.52e-05	0.00166	CcSEcCtD
Fosinopril—Leukopenia—Lisinopril—dilated cardiomyopathy	6.51e-05	0.00166	CcSEcCtD
Fosinopril—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	6.47e-05	0.00165	CcSEcCtD
Fosinopril—Palpitations—Lisinopril—dilated cardiomyopathy	6.43e-05	0.00164	CcSEcCtD
Fosinopril—Loss of consciousness—Lisinopril—dilated cardiomyopathy	6.39e-05	0.00163	CcSEcCtD
Fosinopril—Cough—Lisinopril—dilated cardiomyopathy	6.35e-05	0.00162	CcSEcCtD
Fosinopril—Urticaria—Furosemide—dilated cardiomyopathy	6.28e-05	0.0016	CcSEcCtD
Fosinopril—Abdominal pain—Furosemide—dilated cardiomyopathy	6.25e-05	0.00159	CcSEcCtD
Fosinopril—Body temperature increased—Furosemide—dilated cardiomyopathy	6.25e-05	0.00159	CcSEcCtD
Fosinopril—Arthralgia—Lisinopril—dilated cardiomyopathy	6.19e-05	0.00158	CcSEcCtD
Fosinopril—Chest pain—Lisinopril—dilated cardiomyopathy	6.19e-05	0.00158	CcSEcCtD
Fosinopril—Myalgia—Lisinopril—dilated cardiomyopathy	6.19e-05	0.00158	CcSEcCtD
Fosinopril—Discomfort—Lisinopril—dilated cardiomyopathy	6.12e-05	0.00156	CcSEcCtD
Fosinopril—Dry mouth—Lisinopril—dilated cardiomyopathy	6.06e-05	0.00154	CcSEcCtD
Fosinopril—Confusional state—Lisinopril—dilated cardiomyopathy	5.98e-05	0.00152	CcSEcCtD
Fosinopril—Oedema—Lisinopril—dilated cardiomyopathy	5.94e-05	0.00151	CcSEcCtD
Fosinopril—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	5.94e-05	0.00151	CcSEcCtD
Fosinopril—Infection—Lisinopril—dilated cardiomyopathy	5.9e-05	0.0015	CcSEcCtD
Fosinopril—Shock—Lisinopril—dilated cardiomyopathy	5.84e-05	0.00149	CcSEcCtD
Fosinopril—Hypersensitivity—Furosemide—dilated cardiomyopathy	5.83e-05	0.00148	CcSEcCtD
Fosinopril—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	5.81e-05	0.00148	CcSEcCtD
Fosinopril—Tachycardia—Lisinopril—dilated cardiomyopathy	5.79e-05	0.00148	CcSEcCtD
Fosinopril—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	5.74e-05	0.00146	CcSEcCtD
Fosinopril—Asthenia—Furosemide—dilated cardiomyopathy	5.68e-05	0.00145	CcSEcCtD
Fosinopril—Anorexia—Lisinopril—dilated cardiomyopathy	5.66e-05	0.00144	CcSEcCtD
Fosinopril—Pruritus—Furosemide—dilated cardiomyopathy	5.6e-05	0.00143	CcSEcCtD
Fosinopril—Hypotension—Lisinopril—dilated cardiomyopathy	5.55e-05	0.00141	CcSEcCtD
Fosinopril—Diarrhoea—Furosemide—dilated cardiomyopathy	5.41e-05	0.00138	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	5.41e-05	0.00138	CcSEcCtD
Fosinopril—Insomnia—Lisinopril—dilated cardiomyopathy	5.37e-05	0.00137	CcSEcCtD
Fosinopril—Paraesthesia—Lisinopril—dilated cardiomyopathy	5.33e-05	0.00136	CcSEcCtD
Fosinopril—Dyspnoea—Lisinopril—dilated cardiomyopathy	5.29e-05	0.00135	CcSEcCtD
Fosinopril—Somnolence—Lisinopril—dilated cardiomyopathy	5.28e-05	0.00134	CcSEcCtD
Fosinopril—Dizziness—Furosemide—dilated cardiomyopathy	5.23e-05	0.00133	CcSEcCtD
Fosinopril—Dyspepsia—Lisinopril—dilated cardiomyopathy	5.22e-05	0.00133	CcSEcCtD
Fosinopril—Decreased appetite—Lisinopril—dilated cardiomyopathy	5.16e-05	0.00131	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.14e-05	0.00812	CbGpPWpGaD
Fosinopril—Fatigue—Lisinopril—dilated cardiomyopathy	5.12e-05	0.0013	CcSEcCtD
Fosinopril—Pain—Lisinopril—dilated cardiomyopathy	5.08e-05	0.00129	CcSEcCtD
Fosinopril—Constipation—Lisinopril—dilated cardiomyopathy	5.08e-05	0.00129	CcSEcCtD
Fosinopril—Vomiting—Furosemide—dilated cardiomyopathy	5.03e-05	0.00128	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5e-05	0.0079	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5e-05	0.0079	CbGpPWpGaD
Fosinopril—Rash—Furosemide—dilated cardiomyopathy	4.99e-05	0.00127	CcSEcCtD
Fosinopril—Dermatitis—Furosemide—dilated cardiomyopathy	4.98e-05	0.00127	CcSEcCtD
Fosinopril—Headache—Furosemide—dilated cardiomyopathy	4.96e-05	0.00126	CcSEcCtD
Fosinopril—Feeling abnormal—Lisinopril—dilated cardiomyopathy	4.89e-05	0.00125	CcSEcCtD
Fosinopril—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	4.85e-05	0.00124	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	4.77e-05	0.00754	CbGpPWpGaD
Fosinopril—Urticaria—Lisinopril—dilated cardiomyopathy	4.72e-05	0.0012	CcSEcCtD
Fosinopril—Nausea—Furosemide—dilated cardiomyopathy	4.7e-05	0.0012	CcSEcCtD
Fosinopril—Abdominal pain—Lisinopril—dilated cardiomyopathy	4.69e-05	0.00119	CcSEcCtD
Fosinopril—Body temperature increased—Lisinopril—dilated cardiomyopathy	4.69e-05	0.00119	CcSEcCtD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.65e-05	0.00735	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	4.64e-05	0.00733	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	4.64e-05	0.00733	CbGpPWpGaD
Fosinopril—Hypersensitivity—Lisinopril—dilated cardiomyopathy	4.37e-05	0.00111	CcSEcCtD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.31e-05	0.00682	CbGpPWpGaD
Fosinopril—Asthenia—Lisinopril—dilated cardiomyopathy	4.26e-05	0.00108	CcSEcCtD
Fosinopril—Pruritus—Lisinopril—dilated cardiomyopathy	4.2e-05	0.00107	CcSEcCtD
Fosinopril—Diarrhoea—Lisinopril—dilated cardiomyopathy	4.06e-05	0.00103	CcSEcCtD
Fosinopril—Dizziness—Lisinopril—dilated cardiomyopathy	3.93e-05	0.001	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—LMNA—dilated cardiomyopathy	3.89e-05	0.00614	CbGpPWpGaD
Fosinopril—Vomiting—Lisinopril—dilated cardiomyopathy	3.77e-05	0.000961	CcSEcCtD
Fosinopril—Rash—Lisinopril—dilated cardiomyopathy	3.74e-05	0.000953	CcSEcCtD
Fosinopril—Dermatitis—Lisinopril—dilated cardiomyopathy	3.74e-05	0.000952	CcSEcCtD
Fosinopril—Headache—Lisinopril—dilated cardiomyopathy	3.72e-05	0.000947	CcSEcCtD
Fosinopril—Nausea—Lisinopril—dilated cardiomyopathy	3.53e-05	0.000898	CcSEcCtD
Fosinopril—ACE—Metabolism of proteins—AGT—dilated cardiomyopathy	2.13e-05	0.00336	CbGpPWpGaD
Fosinopril—SLC15A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.01e-05	0.0016	CbGpPWpGaD
Fosinopril—SLC15A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.4e-06	0.00149	CbGpPWpGaD
